These data indicate that even if IFN-α used the mTOR pathway in parallel to inhibit cell growth in RCC, it must play only a minor role, because blocking such activity by temsirolimus did not blunt the effect of 1R-2b, and actually worked in synergy with it to inhibit cell growth. This evidence concerns the gene MTOR and renal cell carcinoma.